AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.24
-2.02 (-4.02%)
Oct 1, 2026, 3:07 PM EDT - Market open
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.44 billion as of October 1, 2026. Its market cap has increased by 68.22% in one year.
Market Cap
1.44B
Enterprise Value
1.55B
1-Year Change
68.22%
Ranking
Category
Stock Price
$48.24
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.44B, an increase of 367.17%. That is a compound annual growth rate of 17.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.44B | 7.44% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.58B |
| Korsana Biosciences | 1.55B |
| Inhibrx Biosciences | 1.54B |
| Innoviva | 1.53B |
| Hemab Therapeutics Holdings | 1.52B |
| Tyra Biosciences | 1.51B |
| Ultragenyx Pharmaceutical | 1.51B |
| Maze Therapeutics | 1.50B |